Kavain vs Pinealon
Side-by-side comparison of Kavain and Pinealon: mechanism, half-life, dose range, safety profile, and vendor pricing.
Price snapshot
Kavain
Pinealon
Kavain
Kavain (kawain) is the principal kavalactone in kava (Piper methysticum) and the main compound behind kava's calming, anxiolytic effect. It positively modulates GABA-A receptors outside the benzodiazepine site and…
No vendor price on file.
Full Kavain profilePinealon
Pinealon is a synthetic tripeptide — glutamyl-aspartyl-arginine (Glu-Asp-Arg, or EDR) — developed by the St Petersburg Institute of Bioregulation and Gerontology (IBG) under the leadership of Professor Vladimir…
Lowest listed price: $45.00 across 3 listings
Full Pinealon profileSide-by-side comparison
| Attribute | Kavain | Pinealon |
|---|---|---|
| Category | Nootropics | Nootropics |
| Research Stage | Preclinical for isolated kavain (in-vitro and animal mechanistic data). Human randomized controlled trials exist for the parent standardized kava extract, of which kavain is the principal kavalactone; the single molecule itself has not been trialed alone. | Preclinical |
| Mechanism of Action | Kavain is the most abundant kavalactone in kava (Piper methysticum) and the main driver of the plant's calming activity. It is a research-use-only compound; the mechanisms below come from in-vitro and animal work on isolated kavain plus human trials of the… | The proposed mechanism of Pinealon is rooted in the Khavinson school's broader theory of short-peptide tissue-specific bioregulation. The full theory is worth understanding because it underlies all twelve Russian bioregulator compounds in this catalog. The… |
| Half-Life | Not firmly established for isolated kavain in humans. Kavalactones are lipophilic and rapidly absorbed, with subjective effects generally lasting a few hours. Limited pharmacokinetic data preclude a precise elimination half-life. | Not formally characterized in humans. Short regulatory peptides of this class are cleared from plasma within minutes; the Khavinson framework proposes durable downstream gene-expression effects that outlast the brief dosing window, which is the stated rationale for pulsed cycling rather than continuous dosing. |
| Typical Dose Range | 50-250 mg | Subcutaneous (primary route): 2-10 mg/day, typically 3-5 mg, in pulsed 10-20 day cycles, 2-4 cycles/year. Intranasal: 150-800 mcg per nostril daily. Research use only; oral dosing is not recommended because the peptide is largely degraded by GI proteases. |
| Dosing Frequency | 1-2 times daily, as needed; not intended for continuous long-term daily use | Once daily during a cycle (morning preferred); some advanced users split into AM + midday doses. Not dosed continuously year-round - cycles are pulsed. |
| Administration | — | — |
| Side Effects | Commonly mild: GI upset/nausea, headache (more headaches were reported in the kava arm than placebo in a GAD trial [PMID:23635869]), daytime drowsiness, and mild dizziness. With chronic heavy use: 'kava dermopathy', a reversible dry, scaly, yellowed skin rash.… | The side-effect profile of Pinealon, based on the available Russian clinical literature and user-reported experience, is described as mild and uncommon. Whether this reflects genuinely low toxicity or inadequate reporting in the available studies is a… |
| Molecular Weight | 230.26 g/mol (C14H14O3; PubChem CID 837). Naturally occurring form is the (+)-enantiomer. | 418.40 g/mol (C15H26N6O8) |
| Common Vial Sizes | — | — |
Price History
2 data points- Ion Peptide
- Disguised Alpha
Kavain: potential benefits
- Reduced anxiety and nervous tension - the parent standardized kava extract (of which kavain is the principal kavalactone) produced a moderate anxiolytic effect versus placebo in generalized anxiety disorder RCTs [PMID:23635869][PMID:19430766]
- Physical and mental relaxation without the heavy sedation or dependence profile of benzodiazepines, since kavain modulates GABA-A outside the benzodiazepine site [PMID:27332705]
- Calming and sleep-onset support, reported anecdotally with evening kava/kavain use (isolated-kavain benefit is extrapolated from extract data plus community use, not directly trialed)
- Mild muscle relaxation and a soothing analgesic feel, consistent with kavain's effects on voltage-gated Na+ and L-type Ca2+ channels [PMID:9690349][PMID:11642654]
- Sociable, clear-headed calm frequently described in traditional and community use of kava beverages
Pinealon: potential benefits
- Neuroprotection against oxidative and hypoxic stress (preclinical models)
- Antioxidant support - reduced oxidative DNA damage in aged neurons (in vitro)
- Cognitive and memory support in aging populations (small Russian clinical reports)
- Reduced neuronal apoptosis and support of dendritic-tree integrity in cell models
- Investigated for neuroprotection in Alzheimer's-model systems (preclinical)
Frequently asked
What's the difference between Kavain and Pinealon?
Kavain is a nootropics that kavain is the most abundant kavalactone in kava (piper methysticum) and the main driver of the plant's calming activity. it is a research-use-only compound; the mechanisms below…. Pinealon is a nootropics that the proposed mechanism of pinealon is rooted in the khavinson school's broader theory of short-peptide tissue-specific bioregulation. the full theory is worth understanding because…. The two differ in mechanism, half-life (Not firmly established for isolated kavain in humans. Kavalactones are lipophilic and rapidly absorbed, with subjective effects generally lasting a few hours. Limited pharmacokinetic data preclude a precise elimination half-life. vs Not formally characterized in humans. Short regulatory peptides of this class are cleared from plasma within minutes; the Khavinson framework proposes durable downstream gene-expression effects that outlast the brief dosing window, which is the stated rationale for pulsed cycling rather than continuous dosing.), and typical dose range.
Which has the longer half-life, Kavain or Pinealon?
Kavain has a half-life of Not firmly established for isolated kavain in humans. Kavalactones are lipophilic and rapidly absorbed, with subjective effects generally lasting a few hours. Limited pharmacokinetic data preclude a precise elimination half-life.. Pinealon has a half-life of Not formally characterized in humans. Short regulatory peptides of this class are cleared from plasma within minutes; the Khavinson framework proposes durable downstream gene-expression effects that outlast the brief dosing window, which is the stated rationale for pulsed cycling rather than continuous dosing.. Longer half-lives generally mean less frequent dosing but slower on/off kinetics.
Can you stack Kavain and Pinealon?
Stacking depends on mechanism overlap, safety profile, and goals. Kavain and Pinealon should only be stacked after reviewing each compound's individual protocol page, side effect profile, and any published interaction data. Use the BodyHackGuide stack builder for a structured review before combining research compounds.
See current vendor prices
Listings from the vendors we track. Prices change often, so check the vendor before you buy.
Before you buy Kavain or Pinealon
Check the vendor trust score. Every supplier we track is rated 0-100 on COA verification, payment transparency, shipping, reviews, and listings: one published, reproducible methodology, applied to every vendor.
Related comparisons
Research use only. BodyHackGuide is a research and price-comparison reference. The compounds discussed on this page are not approved by the FDA for human consumption and are sold strictly for laboratory research. Prices shown are pulled from vendor listings tracked on BHG and are subject to change. Every vendor is ranked on the same public, reproducible methodology. See editorial standards and affiliate disclosure.